These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 22969639)
1. FK228 from Burkholderia thailandensis MSMB43. Liu XY; Wang C; Cheng YQ Acta Crystallogr Sect E Struct Rep Online; 2012 Sep; 68(Pt 9):o2757-8. PubMed ID: 22969639 [TBL] [Abstract][Full Text] [Related]
2. Involvement of extracellular signal-regulated kinase activation in human osteosarcoma cell resistance to the histone deacetylase inhibitor FK228 [(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone]. Matsubara H; Watanabe M; Imai T; Yui Y; Mizushima Y; Hiraumi Y; Kamitsuji Y; Watanabe K; Nishijo K; Toguchida J; Nakahata T; Adachi S J Pharmacol Exp Ther; 2009 Mar; 328(3):839-48. PubMed ID: 19073909 [TBL] [Abstract][Full Text] [Related]
3. Thailandepsin a. Wang C; Cheng YQ Acta Crystallogr Sect E Struct Rep Online; 2011 Nov; 67(Pt 11):o2948-9. PubMed ID: 22219976 [TBL] [Abstract][Full Text] [Related]
4. Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines. Xiao JJ; Huang Y; Dai Z; Sadée W; Chen J; Liu S; Marcucci G; Byrd J; Covey JM; Wright J; Grever M; Chan KK J Pharmacol Exp Ther; 2005 Jul; 314(1):467-75. PubMed ID: 15833893 [TBL] [Abstract][Full Text] [Related]
5. Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1. Xiao JJ; Foraker AB; Swaan PW; Liu S; Huang Y; Dai Z; Chen J; Sadée W; Byrd J; Marcucci G; Chan KK J Pharmacol Exp Ther; 2005 Apr; 313(1):268-76. PubMed ID: 15634944 [TBL] [Abstract][Full Text] [Related]
6. Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factors. Sasakawa Y; Naoe Y; Noto T; Inoue T; Sasakawa T; Matsuo M; Manda T; Mutoh S Biochem Pharmacol; 2003 Sep; 66(6):897-906. PubMed ID: 12963476 [TBL] [Abstract][Full Text] [Related]
7. Marker genes to predict sensitivity to FK228, a histone deacetylase inhibitor. Sasakawa Y; Naoe Y; Sogo N; Inoue T; Sasakawa T; Matsuo M; Manda T; Mutoh S Biochem Pharmacol; 2005 Feb; 69(4):603-16. PubMed ID: 15670579 [TBL] [Abstract][Full Text] [Related]
8. Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo. Sasakawa Y; Naoe Y; Inoue T; Sasakawa T; Matsuo M; Manda T; Mutoh S Biochem Pharmacol; 2002 Oct; 64(7):1079-90. PubMed ID: 12234611 [TBL] [Abstract][Full Text] [Related]
9. Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228. Liu X; Xie F; Doughty LB; Wang Q; Zhang L; Liu X; Cheng YQ Synth Syst Biotechnol; 2018 Dec; 3(4):268-274. PubMed ID: 30417143 [TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a host-guest complex of the tris-urea receptor, 3-(4-nitro-phen-yl)-1,1-bis-{2-[3-(4-nitro-phen-yl)ureido]eth-yl}urea, that encapsulates hydrogen-bonded chains of di-hydrogen phosphate anions with separate tetra- Wang R; Shu X; Fan Y; Li S; Jin Y; Xia C; Huang C Acta Crystallogr E Crystallogr Commun; 2019 Mar; 75(Pt 3):319-323. PubMed ID: 30867940 [TBL] [Abstract][Full Text] [Related]
11. Crystal structures and the Hirshfeld surface analysis of Salian AR; Foro S; Gowda BT Acta Crystallogr E Crystallogr Commun; 2018 Dec; 74(Pt 12):1710-1716. PubMed ID: 30574361 [TBL] [Abstract][Full Text] [Related]
12. Crystal structures of the 1:1 salts of 2-amino-4-nitro-benzoate with each of (2-hy-droxy-eth-yl)di-methyl-aza-nium, Wardell JL; Tiekink ERT Acta Crystallogr E Crystallogr Commun; 2018 Dec; 74(Pt 12):1735-1740. PubMed ID: 30574365 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure and Hirshfeld surface analysis of ethyl 2-[9-(2-hy-droxy-phen-yl)-3,3,6,6-tetra-methyl-1,8-dioxo-2,3,4,4a,5,6,7,8a,9,9a,10,10a-dodeca-hydro-acridin-10-yl]acetate. Allah OAAA; Kaur M; Akkurt M; Mohamed SK; Jasinski JP; Elgarhy SMI Acta Crystallogr E Crystallogr Commun; 2021 Mar; 77(Pt 3):247-250. PubMed ID: 33953945 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure and Hirshfeld surface analysis of ( Naghiyev FN; Pavlova AV; Khrustalev VN; Akkurt M; Khalilov AN; Akobirshoeva AA; Mamedov İG Acta Crystallogr E Crystallogr Commun; 2021 Sep; 77(Pt 9):930-934. PubMed ID: 34584764 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of tetra-methyl-tetra-thia-fulvalenium (1S)-camphor-10-sulfonate dihydrate. Sommer M; Allain M; Mézière C; Pop F; Giffard M Acta Crystallogr E Crystallogr Commun; 2015 Jul; 71(Pt 7):748-51. PubMed ID: 26279858 [TBL] [Abstract][Full Text] [Related]
18. The crystal structures of 3- Clarke Z; Barnes E; Prichard KL; Mares LJ; Clegg JK; McCluskey A; Houston TA; Simone MI Acta Crystallogr E Crystallogr Commun; 2018 Jun; 74(Pt 6):862-867. PubMed ID: 29951246 [TBL] [Abstract][Full Text] [Related]
19. (1S,2R,4S)-1-[(Benzyl-amino)-meth-yl]-4-(prop-1-en-2-yl)cyclo-hexane-1,2-diol. Outouch R; Boualy B; Ali MA; Firdoussi LE; Rizzoli C Acta Crystallogr Sect E Struct Rep Online; 2010 Dec; 67(Pt 1):o195-6. PubMed ID: 21522697 [TBL] [Abstract][Full Text] [Related]
20. Crystal structures of two hydrazide derivatives of mefenamic acid, 3-(2,3-di-methyl-anilino)- Mohamed SK; Mague JT; Akkurt M; Albayati MR; Elgarhy SMI; Al-Taifi EA Acta Crystallogr E Crystallogr Commun; 2021 Mar; 77(Pt 3):242-246. PubMed ID: 33953944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]